Amylyx Pharmaceuticals (AMLX) Competitor Comparison
We are evaluating the key criteria listed to compare Amylyx Pharmaceuticals (AMLX) against its competitors in the Biotechnology industry.
Market Capitalization
111 / 368Gross Profits
218 / 278Total Revenue
40 / 300EBITDA
46 / 337Free Cashflow
164 / 352Quick Ratio
103 / 357Earnings per Share
279 / 359Dividend yield
0 / 6Total Cash
89 / 358Performance 3 years
199 / 368Performance 5 years
207 / 368Performance 10 years
182 / 368Linearity 3 years
73 / 368Linearity 5 years
120 / 368Linearity 10 years
76 / 368Total Rank
111 / 368Dividend Rank
349 / 368Valuation Rank
293 / 368Piotroski Rank
75 / 368Muliplier Rank
267 / 368Linearity 5 years - AMLX ranking 120 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.